Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer-Reference-Cited by-同舟云学术

Toward operative in vivo fluorescence imaging of the c-Met proto-oncogene for personalization of therapy in ovarian cancer

Published:2014-09-10 Issue:2 Volume:121 Page:202-213
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Liu Shujuan¹²³,Zheng Yong¹²,Volpi Davide⁴,El-Kasti Muna¹²,Klotz Daniel¹²,Tullis Iain⁴,Henricks Andrea¹²,Campo Leticia⁴,Myers Kevin⁴,Laios Alex¹²,Thomas Peter⁴,Ng Tony⁵,Dhar Sunanda⁶,Becker Christian²,Vojnovic Borivoj⁴,Ahmed Ahmed Ashour¹²

Affiliation:

1. Weatherall Institute of Molecular Medicine; University of Oxford; Oxford United Kingdom

2. Nuffield Department of Obstetrics and Gynaeoclogy; Women's Centre, John Radcliffe Hospital; Oxford United Kingdom

3. Department of Obstetrics and Gynecology, Xijing Hospital; Fourth Military Medical University; Xi'an China

4. Department of Oncology; University of Oxford; Oxford United Kingdom

5. Richard Dimbleby Department of Cancer Research; King's College; London United Kingdom

6. Department of Histopathology; Oxford University Hospitals; Oxford United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a Gynecologic Oncology Group study;Muggia;J Clin Oncol,2000

2. The role of laparoscopy in second-look evaluations for ovarian cancer;Husain;Gynecol Oncol,2001

3. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings;Rubin;Obstet Gynecol,1999

4. Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study;Gadducci;Gynecol Oncol,1998

5. Microscopic disease at second-look laparotomy in advanced ovarian cancer;Copeland;Cancer,1985

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides for diagnosis and treatment of ovarian cancer;Frontiers in Oncology;2023-05-05

2. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker;Molecular Oncology;2021-04-07

3. Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?;Archives of Gynecology and Obstetrics;2020-08-24

4. Indocyanine green fluorescence-guided intraoperative detection of peritoneal carcinomatosis: systematic review;BMC Surgery;2020-07-17

5. Fluorescent cyclic peptides for cell imaging;Peptide Science;2020-07-02